Sorafenib Completed Phase 2 Trials for Melanoma Stage III or IV / No Prior Chemotherapy Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00794235Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine